Document is current

Article History

Received: 13 February 2025

Accepted: 8 April 2025

First Online: 26 April 2025

Declarations

:

: Pedro Mendes-Bastos has received honoraria for acting as consultant/speaker/principal Investigator for AbbVie, Almirall, Amgen, Apogee, Biogen, CS Labs, Eli-Lilly, Evelo Biosciences, Janssen-Cilag, Leo-Pharma, L’Oreal, Novartis, Organon, Pfizer, Pierre Fabre, Regeneron, Sanofi, and Viatris. Elisavet Lazaridou has received honoraria for acting as a consultant and/or as a speaker for Abbvie, UCB, Novartis, Janssen, Pfizer, LEO Pharma, Amgen, Sanofi, Pharmaserve Lilly, Pierre Fabre, L’oreal, and Genesis Pharma. Elisavet Lazaridou served as an investigator in clinical trials supported by Abbvie, UCB, Janssen, Leo, Amgen, L’oreal, and Boehringer Ingelheim. Tiago Torres has received honoraria for acting as a consultant and/or as a speaker for Abbvie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers-Squibb, Celgene, Janssen, LEO Pharma, Eli-Lilly, MSD, Mylan, Novartis, Pfizer, Sanofi Genzyme, Sandoz, Samsung-Bioepis, UCB, and Viatris. Tiago Torres is or has been a principal investigator in clinical trials supported by AbbVie, Amgen, Janssen, Novartis, and Sanofi. Tiago Torres is an Editorial Board member of Dermatology and Therapy. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Charalampos Aggelakopoulos has no conflicts of interest. Ioannis Katsantonis is or has been a principal investigator in clinical trials supported by AbbVie, UCB, Novartis, LEO Pharma, and Amgen. Pantelis Aronis has no conflicts of interest. Dimitrios Rigopoulos has received honoraria for acting as a consultant and/or as a speaker for AbbVie, Genesis Pharma, Amgen, UCB, Novartis, and LEO Pharma. Dimitrios Rigopoulos served as an investigator in clinical trials supported by AbbVie, Genesis Pharma, Amgen, UCB, and Novartis. Current affiliation of Dimitrios Rigopoulos is Hygeia Hospital, Kifisias Av. 151 23, Marousi, Athens, Greece. Filomena Azevedo has no conflicts of interest. Felicidade Santiago has no conflicts of interest. Current affiliation of Felicidade Santiago is Unidade Local de Saúde de Coimbra, Praceta Professor Mota Pinto, 3004–561 Coimbra, Portugal. Markos Papakonstantis served as an investigator and/or consultant or speaker for AbbVie, Faran, Janssen, LEO Pharma, Pharmaserve Lilly, Novartis, Pfizer, and UCB. Paulo Varela served as an investigator and/or consultant or speaker for Abbvie, Almirall, Boehringer, Janssen, Leo, Lilly, Pfizer, Sandoz, and Sanofi. Vera S. G. Ribeiro and Aikaterini Kollia are employees of AbbVie Pharmaceuticals. Evaggelia Papadavid has received honoraria for acting as a consultant and/or as a speaker for AbbVie, Janssen, UCB, Novartis, Pharmaserve Lilly, Amgen, Takeda, Recordati, and Pfizer. Evaggelia Papadavid served as an investigator in clinical trials supported by Helsinn, Recordati, Novartis, and Janssen.

: This study received approval from the institutional review boards of all involved institutions. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All subjects (or that person’s parent or legal guardian) provided informed consent to participate in the study.